Researcher
Julia Katharina Schwarze
- Keywords:Medicine
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Laboratory for Medical and Molecular Oncology (Research group)
Member
From22 Mar 2021 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From4 Sep 2018 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From28 Sep 2015 → Today - Internal medicine (Department)
Member
From1 Oct 2023 → Today - Clinical sciences (Department)
Member
From1 Jun 2022 → Today - Clinical sciences (Department)
Member
From8 Apr 2019 → 31 May 2022 - Internal medicine (Department)
Member
From1 Sep 2018 → 30 Sep 2022 - Medical Oncology (Department)
Member
From2 Jul 2018 → 31 Aug 2018 - Clinical sciences (Department)
Member
From1 Jun 2018 → 31 May 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From11 May 2018 → 14 Dec 2023 - Faculty of Medicine and Pharmacy (Faculty)
Member
From21 Sep 2012 → 26 Jun 2014
Publications
21 - 26 of 26
- Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy(2019)
Authors: Teofila Seremet, Yanina Jansen, Simon Planken, Hassan Njimi, Melanie Delaunoy, Hakim El Housni, Gil Awada, Julia Katharina Schwarze, Marleen Keyaerts, Hendrik Everaert, et al.
- Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors(2019)
Authors: Anne Rogiers, Annelies Boekhout, Julia Katharina Schwarze, Gil Awada, Christian Blank, Bart Neyns
- The clinical application of cancer immunotherapy based on naturally circulating dendritic cells(2019)
Authors: Kalijn F Bol, Gerty Schreibelt, Katrin Rabold, Stefanie K Wculek, Julia Katharina Schwarze, Andrzej Dzionek, Alvaro Teijeira, Lana E Kandalaft, Pedro Romero, George Coukos, et al.
- Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma(2019)
Authors: Teofila Seremet, Simon Planken, Julia Katharina Schwarze, Yanina Jansen, Laura Vandeweerd, Robbe Van den Begin, Ioannis Tsechelidis, Danielle Lienard, Veronique Del Marmol, Bart Neyns
Pages: 85-88 - Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion(2016)
Authors: Wim Leonard, Inès Dufait, Julia Katharina Schwarze, Lun Law Ka, Benedikt Engels, H. Jiang, Dirk Van den Berge, Thierry Gevaert, Guy Storme, Valeri N. Verovski, et al.
Pages: 291-299 - Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy(2014)
Authors: Therese Liechtenstein, Noemi Perez-Janices, Idoia Blanco-Luquin, Cleo Goyvaerts, Julia Katharina Schwarze, Inès Dufait, Alessio Lanna, Mark De Ridder, David Guerrero-Setas, Karine Breckpot, et al.